Association between common variants near the melanocortin 4 receptor gene and severe antipsychotic drug-induced weight gain - Wikidata - awgldk - TriplyDB

Association between common variants near the melanocortin 4 receptor gene and severe antipsychotic drug-induced weight gain

Association between common variants near the melanocortin 4 receptor gene and severe antipsychotic drug-induced weight gain

http://www.wikidata.org/entity/Q28266158

about

Decoding the non-coding genome: elucidating genetic risk outside the coding genome Pharmacogenetics and outcome with antipsychotic drugs Genetics of Common Antipsychotic-Induced Adverse Effects Treatment-resistant schizophrenia: current insights on the pharmacogenomics of antipsychotics Progress in understanding the genomic basis for adverse drug reactions: a comprehensive review and focus on the role of ethnicity MC4R rs489693: a clinical risk factor for second generation antipsychotic-related weight gain?Schizophrenia.Molecular substrates of schizophrenia: homeostatic signaling to connectivity Towards the clinical implementation of pharmacogenetics in bipolar disorder.Comparative efficacy and safety of antipsychotics in the treatment of schizophrenia: a network meta-analysis in a Japanese population.Pharmacogenetics of antipsychotics.Identification of candidate single-nucleotide polymorphisms in NRXN1 related to antipsychotic treatment response in patients with schizophrenia.The role of leptin, melanocortin, and neurotrophin system genes on body weight in anorexia nervosa and bulimia nervosa.Managing cardiovascular disease risk in patients treated with antipsychotics: a multidisciplinary approach Association between MC4R rs17782313 polymorphism and overeating behaviors.Positive perception of pharmacogenetic testing for psychotropic medications Aripiprazole for the management of schizophrenia in the Japanese population: a systematic review and meta-analysis of randomized controlled trials.Genome-wide association studies in Africans and African Americans: expanding the framework of the genomics of human traits and disease.Pharmacogenetics of clozapine treatment response and side-effects in schizophrenia: an update.Influence of MCHR2 and MCHR2-AS1 Genetic Polymorphisms on Body Mass Index in Psychiatric Patients and In Population-Based Subjects with Present or Past Atypical Depression.Taking Personalized Medicine Seriously: Biomarker Approaches in Phase IIb/III Studies in Major Depression and Schizophrenia Recent advances in understanding and mitigating adipogenic and metabolic effects of antipsychotic drugs.An Economic Evaluation of a Weight Loss Intervention Program for People with Serious Mental Illnesses Taking Antipsychotic Medications Pharmacogenetics of antipsychotics: recent progress and methodological issues.Genetic variants associated with response to lithium treatment in bipolar disorder: a genome-wide association study Genome-Wide Association Study Suggested the PTPRD Polymorphisms Were Associated With Weight Gain Effects of Atypical Antipsychotic Medications.Is Metabolic Syndrome On the Radar? Improving Real-Time Detection of Metabolic Syndrome and Physician Response by Computerized Scan of the Electronic Medical Record Moderation of antipsychotic-induced weight gain by energy balance gene variants in the RUPP autism network risperidone studies.Genes and schizophrenia: from a Festschrift Seminar honoring William T. Carpenter Jr, MD.Cardiometabolic outcomes in children and adolescents following discontinuation of long-term risperidone treatment.TOX and ADIPOQ Gene Polymorphisms Are Associated with Antipsychotic-Induced Weight Gain in Han Chinese.Weight gain and increase of body mass index among children and adolescents treated with antipsychotics: a critical review.Novel "thrifty" models of increased eating behaviour.Pharmacogenetics in schizophrenia: a review of clozapine studies.Clinical validity of cytochrome P450 metabolism and serotonin gene variants in psychiatric pharmacotherapy.Safety profile of iloperidone in the treatment of schizophrenia.Genetics of antipsychotic-induced weight gain: update and current perspectives.Individualizing clozapine and risperidone treatment for schizophrenia patients.Directions for future patient-centered and comparative effectiveness research for people with serious mental illness in a learning mental health care system Pharmacogenetics of second-generation antipsychotics.

P2860

Q26777924-DF5A2468-D4F7-4908-B8F7-9BAB610243A0 Q26852807-2273E20B-5B00-4437-8495-2DCC018C7C9D Q28072893-BBF03E0D-F41A-406C-9989-B4B5EDCBE679 Q28079065-4BE80EBA-180B-4FC6-AB3D-A8AE02808AB2 Q28083100-45D22B7F-2798-4E12-BAC8-BC2AEF37BAEE Q28296094-B8798DF0-36F5-4C95-A758-42C62E231B7F Q30251961-6EA2D1FB-5A32-43EC-8F83-BFF3450D339B Q30383611-B185479D-CD5A-40E2-87BF-9F808BF15AD7 Q33688133-84C4C20E-955C-44E5-B266-F2116FEF4799 Q33713759-867ABB4B-4370-441C-B666-7AF89CA90F80 Q33836837-5F3CA549-2A0D-4BEF-95B3-98C07435325C Q33923615-11B2F2BE-68D6-4635-AA33-2E047AED8EF2 Q34315012-12A5240A-8402-4D7D-8DDB-9A16E50F81D7 Q34464293-EC674DE2-8320-429F-B683-E2DCFB8FC708 Q34514174-4BCBE497-834C-4BAE-B87C-44B5462656AA Q34541288-1AA2EE7E-1E95-425B-B701-1FBCBA4EB64E Q35136085-D8BD28D5-220C-42D9-BBF1-F95843F4F8E9 Q35565624-72F8BBC1-2D74-48D1-A5CE-5538ADFAE469 Q35771833-38D0CE99-34E5-4CAE-BCE4-D09ADE7865C9 Q35804713-1F149616-B286-40D5-AE01-13202132579E Q36063627-424A65C1-88D8-4E74-A907-4EB6B1D5A91B Q36063735-06163CEE-0AB1-4609-8FDB-62608EA442A8 Q36441253-E1DEC3C5-339C-4713-8AF1-B83C922353E4 Q36539833-602A28D5-F395-4D10-BF31-63AE1F97AD81 Q36746449-AA5C6DAF-7067-460E-9D34-A6C03B235AA6 Q36817242-355BA066-60AB-42B7-9B3E-E37F48C108F6 Q36921831-77633D06-0E42-45AC-A0C1-066ED15F2AF6 Q36956632-0B040F3E-C11C-4203-9D9A-D91A9CE1781E Q37602618-F655888E-5174-434B-A72E-A48365C397EF Q37712697-3808E4B4-C876-4B6C-9478-C61121147339 Q37714911-01AFCB95-AB9F-4DA6-B6A5-8C862C708AFA Q38090490-9216C04A-1113-4FC5-A297-1E1FEA9D3CA1 Q38140664-55C09EC7-AAF2-466D-897F-E89A3958DF92 Q38154175-4F861FC9-CF74-46CA-AA46-0A9759B9FFCC Q38154911-EA3F369A-D264-4218-BF3E-FA0F81FC5894 Q38160942-C3882295-57D5-420A-894C-ECC41838DC0E Q38166456-0B08B167-C141-4575-AD1C-60CB23E70380 Q38170458-92485D76-D11D-4376-A403-A71D5D1D07B8 Q38184528-A683F07B-4730-44AA-B165-E88EFC629759 Q38217628-375DC9EF-EE8F-4577-B4AF-7CDFE9B47B8B

P2860

Association between common variants near the melanocortin 4 receptor gene and severe antipsychotic drug-induced weight gain

http://www.wikidata.org/entity/Q28266158

description

2012 nî lūn-bûn

@nan

2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Association between common var ...... hotic drug-induced weight gain

@ast

Association between common var ...... hotic drug-induced weight gain

@en

Association between common var ...... hotic drug-induced weight gain

@nl

type

label

Association between common var ...... hotic drug-induced weight gain

@ast

Association between common var ...... hotic drug-induced weight gain

@en

Association between common var ...... hotic drug-induced weight gain

@nl

prefLabel

Association between common var ...... hotic drug-induced weight gain

@ast

Association between common var ...... hotic drug-induced weight gain

@en

Association between common var ...... hotic drug-induced weight gain

@nl

P1433

Q28266158-22E28C57-950D-438B-BCD4-6297040D8B3B

P1476

Q28266158-515B23CB-0831-44B5-8758-6A73F16BD7CC

P2093

Q28266158-0F826FAB-196C-4E05-AB02-9D5E26B57E05

Q28266158-225C606C-2624-4C70-B6A3-199458DFF24D

Q28266158-631A305F-15FF-4F28-96CC-B47834A7F40B

Q28266158-70FDEE70-B584-49CF-BFFE-A75D7DF1E408

Q28266158-73E1901C-CFE3-4292-BC42-56561737DD75

Q28266158-8FAF8C15-9F38-4600-B5F4-C8B1A78FF5FC

Q28266158-AC3A2AF2-AD32-4C0A-A60D-D225D69D5FAD

Q28266158-BC101867-97EC-45FB-A14A-EDF22DBB0767

Q28266158-D37B5A40-FBDF-4D51-AB0C-76592EE5D960

Q28266158-D94AA734-DECB-4963-AD21-46F92574BD27

P2860

Q28266158-03B4A316-03F3-4CFE-ADF5-74219D6F6B89

Q28266158-09D98553-4857-4BA4-88F5-F0A8ED8CFF2B

Q28266158-0D544867-D6C3-465E-AB20-BB6A3230171A

Q28266158-18F8C042-C5BB-405F-85D6-CE7CE1B02A5A

Q28266158-1BD47F18-9887-4E7E-8FD7-4AB1A8F52B10

Q28266158-1BFB832E-764E-4562-AB03-A79CDF8982FE

Q28266158-208267D7-AD32-4A33-93B1-A255347BED82

Q28266158-293CE645-5E42-4009-825F-F3902DDA1FAB

Q28266158-29A6765E-1C3B-4423-8546-2B073A5B32FC

Q28266158-2B8F1662-938C-4E30-981C-DC381556F60D

P304

Q28266158-247DFCA0-E4EE-4291-BC77-8B2D77C94413

P31

Q28266158-88EF0140-0B80-4CB3-B826-2739D9C60E2A

P3181

Q28266158-07481343-4F44-4DCE-9D5E-BDF05172ADB9

P356

Q28266158-08CD7DE2-3F90-425B-A185-79165B10DE44

P407

Q28266158-CEF0A669-5D04-46F4-A1B4-2DA76BF4049D

P433

Q28266158-3D2B8336-5333-421A-8CEC-90D29D6ABE01

P478

Q28266158-3E2E5B79-6DAD-4D5B-BD9B-1A08CFD4AB74

P50

Q28266158-76128910-511B-4E2E-AD02-D12ED930F18E

Q28266158-80B95CF6-520A-4FF5-8EA7-CF112B38D449

Q28266158-BA08DC1B-0A53-4373-821A-9FB7E34D2B66

P577

Q28266158-4498255C-7636-4D04-882D-C631EB882A9B

P5875

Q28266158-DA499704-9A69-49C9-9971-2BDC17F186C5

P698

Q28266158-9CDA349E-D70E-4AA8-9652-C30C29368220

P921

Q28266158-2DF0965B-3CE9-485E-8232-18E7B921CF40

P932

Q28266158-F0CFA4C9-5E24-4273-8421-DFF8605938FE

P3181

P356

ARCHGENPSYCHIATRY.2012.191

P1433

JAMA Psychiatry

P1476

Association between common var ...... hotic drug-induced weight gain

@en

P2093

Anil K Malhotra

http://www.w3.org/2001/XMLSchema#string

Annette T Lee

http://www.w3.org/2001/XMLSchema#string

Arun K Tiwari

http://www.w3.org/2001/XMLSchema#string

Christoph U Correll

http://www.w3.org/2001/XMLSchema#string

Daniel J Müller

http://www.w3.org/2001/XMLSchema#string

Herbert Y Meltzer

http://www.w3.org/2001/XMLSchema#string

James L Kennedy

http://www.w3.org/2001/XMLSchema#string

John M Kane

http://www.w3.org/2001/XMLSchema#string

Nabilah I Chowdhury

http://www.w3.org/2001/XMLSchema#string

Roel A Ophoff

http://www.w3.org/2001/XMLSchema#string

P2860

NRXN3 is a novel locus for waist circumference: a genome-wide association study from the CHARGE Consortium

A genome-wide association study of the metabolic syndrome in Indian Asian men

Management of antipsychotic-related weight gain

Genomewide pharmacogenomic study of metabolic side effects to antipsychotic drugs

Common variants near MC4R are associated with fat mass, weight and risk of obesity

Six new loci associated with body mass index highlight a neuronal influence on body weight regulation

PLINK: a tool set for whole-genome association and population-based linkage analyses

Principal components analysis corrects for stratification in genome-wide association studies

Common genetic variation near MC4R is associated with waist circumference and insulin resistance

Targeted disruption of the melanocortin-4 receptor results in obesity in mice

P304

904-12

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2650621

http://www.w3.org/2001/XMLSchema#string

P356

10.1001/ARCHGENPSYCHIATRY.2012.191

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

69

http://www.w3.org/2001/XMLSchema#string

P50

Peter K. Gregersen

P577

2012-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

224918953

http://www.w3.org/2001/XMLSchema#string

P698

22566560

http://www.w3.org/2001/XMLSchema#string

P921

P932

4166499

http://www.w3.org/2001/XMLSchema#string